Open original FDA record ↗Recall record
- FDA identifier
- Z-1491-2014
- Company in FDA record
- Abbott Molecular
- FDA classification date
- Apr 23, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
20 kits of CEP 8 SG ASR Probe (list 06J37-018, lot 440023), contained Vysis CEP 4 (Alpha Satellite) SG Probe, 20u, (part 32-112004 lot 438814), instead of the expected CEP 8 probe.
Source facts
- Action
- Customers were sent Field Correction Notices dated 3/28/13 instructing them to inspect their CEP 8 SpectrumGreen Probe kits for the presence of CEP4 probe vials. If any CEP4 vials are discovered, customers should contact their local Abbott Molecular Technical Support Represtative for coordination of reagent replacement with the correct CEP8 vial. If customers have any specific questions they can contact Abbott Molecular at 1-800-553-7042, Option 2.
- Initiated
- 2013-03-28
- Root cause
- Packaging change control
- Terminated
- 2016-03-08
- Distribution
- Nationwide (CA, CO, CT, FL, HI, IL, IN, MA, MD, MI, MN, MO, MT, NC, NE, NJ, NM, NV, NY, OH, OR, PA, TN, TX, VA, WA, WI); Canada
- Recall number
- Z-1491-2014
- Recall status
- Terminated
- CDRH record ID
- 126356
- FDA classified
- 2014-04-23
- Recall event number
- 64791